JT
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Relevance and limitations of clinical follow-up in a pharmacokinetic study on direct oral anticoagulants | Frontiers in pharmacology |  | 2026 | 1 | 0 | ||
| Cytochrome P450 phenotyping using the Geneva cocktail improves metabolic capacity prediction in a hospitalized patient population | British journal of clinical pharmacology |  | 2025 | 44 | 0 | ||
| Inadequate imipenem dosing in patients with decreased kidney function : a global clinical pharmacokinetic study | Clinical microbiology and infection | | 2025 | 2 | 4 | ||
| Improving Understanding of Fexofenadine Pharmacokinetics to Assess Pgp Phenotypic Activity in Older Adult Patients Using Population Pharmacokinetic Modeling | Clinical pharmacokinetics | | 2025 | 64 | 84 | ||
| The Impact of Dexamethasone and Prednisone on Apixaban and Rivaroxaban Exposure in COVID-19 Patients : A Physiologically Based Pharmacokinetic Modeling Study | Clinical pharmacology and therapeutics | | 2025 | 70 | 277 | ||
| Virtual twin approach using physiologically based pharmacokinetic modelling in hospitalized patients treated with apixaban or rivaroxaban | British journal of clinical pharmacology | | 2025 | 75 | 0 | ||
| Guidance on selecting optimal steady-state tacrolimus concentrations for continuous IV perfusion : insights from physiologically based pharmacokinetic modeling | Pharmaceuticals | | 2024 | 99 | 201 | ||
| CYP450 3A4/5 Containment During SARS-CoV-2 Infection | Clinical pharmacology and therapeutics | | 2023 | 81 | 91 | ||
| Apixaban and rivaroxaban's physiologically-based pharmacokinetic model validation in hospitalized patients: A first step for larger use of a priori modeling approach at bed side | CPT: pharmacometrics & systems pharmacology | | 2023 | 143 | 372 | ||
| Clinicians’ adherence to guidelines for the preoperative management of direct oral anticoagulants in a tertiary hospital: a retrospective study | BMC anesthesiology | | 2023 | 96 | 215 | ||
| Population pharmacokinetics of apixaban in a real-life hospitalized population from the OptimAT study | CPT: pharmacometrics & systems pharmacology | | 2023 | 132 | 332 | ||
| A bilateral aseptic pyogenic ventriculitis following a course of pembrolizumab, an anti-PD-1 immune checkpoint inhibitor treatment for metastatic small cell lung cancer | Thérapie | | 2022 | 54 | 0 | ||
| Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting | Journal of personalized medicine | | 2022 | 225 | 323 | ||
| Population Pharmacokinetic Models for Direct Oral Anticoagulants: A Systematic Review and Clinical Appraisal Using Exposure Simulation | Clinical pharmacology and therapeutics | | 2022 | 164 | 257 | ||
| Liquid Biopsy for Patient Characterization in Cardiovascular Disease: Verification against Markers of Cytochrome P450 and P-Glycoprotein Activities | Clinical pharmacology and therapeutics | | 2022 | 180 | 375 | ||
| Impact of SARS-CoV-2 Infection (COVID-19) on Cytochromes P450 Activity Assessed by the Geneva Cocktail | Clinical pharmacology and therapeutics | | 2021 | 212 | 212 | ||
| Drug-drug interactions with direct oral anticoagulants: practical recommendations for clinicians | The American journal of medicine | | 2021 | 176 | 0 | ||
| Mixing Drugs and Genetics: A Complex Hemorrhagic Cocktail | American Journal of Medicine | | 2021 | 286 | 5 | ||
| Clinical and Pharmacological Considerations for Concomitant Administration of Posaconazole and Isavuconazole with Letermovir | Antimicrobial agents and chemotherapy | | 2021 | 250 | 424 | ||
| Towards personalized antithrombotic treatments: focus on P2Y12 inhibitors and direct oral anticoagulants | Clinical Pharmacokinetics | | 2019 | 503 | 2 | ||
| Cell-Type Specific Insertion of GluA2-Lacking AMPARs with Cocaine Exposure Leading to Sensitization, Cue-Induced Seeking, and Incubation of Craving | Neuropsychopharmacology | | 2016 | 652 | 131 | ||
| [Mesolimbic dopamine neuron stimulation is sufficient for the progression to addiction] | MS. Médecine sciences | | 2016 | 485 | 0 | ||
| Exploring synaptic causalities in addictive behaviors | | 2014 | 757 | 22 | |||
| Contrasting forms of cocaine-evoked plasticity control components of relapse | Nature | | 2014 | 1,083 | 908 | ||
| Bi-directional effect of increasing doses of baclofen on reinforcement learning | Frontiers in behavioral neuroscience | | 2011 | 727 | 276 |
